AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35945599 — intervention group
Group type: EXPERIMENTAL
Intervention: ATSB + universal vector control
Number of subjects: 3850
Study 35945599 — intervention group
Group type: COMPARATOR
Intervention: Universal vector control alone
Number of subjects: 3850
Study 33754627 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically driven serum TSH
Number of subjects: 0
Study 33754627 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted high BMI
Number of subjects: 0
Study 33754627 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 0
Study 32838800 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based patient decision aid (PtDA) for hip OA
Number of subjects: 124
Study 32838800 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 124
Study 35606763 — intervention group
Group type: EXPERIMENTAL
Intervention: SHIFT intervention (n = 183)
Number of subjects: 382
Study 35606763 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 199)
Number of subjects: 382
Study 34936273 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupoint thread-embedding combined with fluticasone propionate aerosol
Number of subjects: 120
Study 34936273 — intervention group
Group type: COMPARATOR
Intervention: Fluticasone propionate aerosol (125 μg per inhalation, twice a day)
Number of subjects: 120
Study 32816578 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitine (1000 mg/day)
Number of subjects: 75
Study 32816578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 34192297 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep extension (1 hour earlier bedtime)
Number of subjects: 105
Study 34192297 — intervention group
Group type: COMPARATOR
Intervention: Sleep restriction (1 hour later bedtime)
Number of subjects: 105
Study 34192297 — intervention group
Group type: EXPERIMENTAL
Intervention: Second week of intervention (learning effect)
Number of subjects: 105
Study 34192297 — intervention group
Group type: EXPERIMENTAL
Intervention: Underpowered parallel analysis during sleep deprivation
Number of subjects: 105
Study 32389396 — intervention group
Group type: EXPERIMENTAL
Intervention: Zurich Observation Pain Assessment (ZOPA)
Number of subjects: 24
Study 32389396 — intervention group
Group type: EXPERIMENTAL
Intervention: Critical Care Pain Observation Tool (CPOT)
Number of subjects: 24
Study 32389396 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural Pain Scale (BPS)
Number of subjects: 24
Study 32389396 — intervention group
Group type: EXPERIMENTAL
Intervention: All tools (ZOPA, CPOT, BPS)
Number of subjects: 24
Study 32389396 — intervention group
Group type: EXPERIMENTAL
Intervention: Analgesics provided
Number of subjects: 24
Study 35263314 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-gauge pars plana vitrectomy (PPV) with antivascular endothelial growth factor pretreatment
Number of subjects: 943
Study 32214296 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyalase + 10 mL saline solution injection
Number of subjects: 60
Study 32214296 — intervention group
Group type: COMPARATOR
Intervention: 10 mL saline solution only
Number of subjects: 60
Study 34448748 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory syncytial virus (RSV)
Number of subjects: 882
Study 34448748 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculosis (TB)
Number of subjects: 882
Study 32997666 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient and EED Assessment Tool (MEEDAT)
Number of subjects: 300
Study 33267591 — intervention group
Group type: EXPERIMENTAL
Intervention: Almagate (1.5 g)
Number of subjects: 0
Study 35301643 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Health Now intervention (education tools, onsite practice facilitation for one year, practice-specific cardiovascular population management dashboard)
Number of subjects: 28
Study 34306599 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi softball (TCSB) training program
Number of subjects: 100
Study 34306599 — intervention group
Group type: COMPARATOR
Intervention: Physical exercise group
Number of subjects: 100
Study 32624208 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented locking plate fixation (Group LP)
Number of subjects: 60
Study 32624208 — intervention group
Group type: COMPARATOR
Intervention: Intramedullary nailing (Group IN)
Number of subjects: 60
Study 35932526 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep brain stimulation (DBS) of bilateral thalamic centromedian nucleus for 3 months
Number of subjects: 19
Study 32364518 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS group
Number of subjects: 40
Study 32364518 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study 35380664 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg BID
Number of subjects: 0
Study 33496985 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training + saffron (RTS)
Number of subjects: 100
Study 33496985 — intervention group
Group type: EXPERIMENTAL
Intervention: Saffron (S)
Number of subjects: 100
Study 33496985 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT)
Number of subjects: 100
Study 33496985 — intervention group
Group type: COMPARATOR
Intervention: Control group (CO)
Number of subjects: 100
Study 35773711 — intervention group
Group type: EXPERIMENTAL
Intervention: Phasic muscle therapy protocol using the StimaWELL 120MTRS system
Number of subjects: 30
Study 35773711 — intervention group
Group type: COMPARATOR
Intervention: Combined muscle therapy protocol (phasic + tonic) using the StimaWELL 120MTRS system
Number of subjects: 30
Study 35773711 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (phasic and combined)
Number of subjects: 30
Study 33792839 — intervention group
Group type: COMPARATOR
Intervention: Standard peritoneal lavage (SPL)
Number of subjects: 94
Study 33792839 — intervention group
Group type: EXPERIMENTAL
Intervention: Extensive intraoperative peritoneal lavage (EIPL)
Number of subjects: 94
Study 33792839 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic approach
Number of subjects: 94
Study 32272256 — intervention group
Group type: EXPERIMENTAL
Intervention: No-touch technique for saphenous vein grafts (SVGs)
Number of subjects: 900
Study 32272256 — intervention group
Group type: COMPARATOR
Intervention: Conventional open skeletonized technique for saphenous vein grafts (SVGs)
Number of subjects: 900
Study 36244527 — intervention group
Group type: EXPERIMENTAL
Intervention: Gabapentin (1800 mg/day)
Number of subjects: 13
Study 36244527 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0 mg/day)
Number of subjects: 13
Study 34531218 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fat transfer (AFT)
Number of subjects: 196
Study 34531218 — intervention group
Group type: COMPARATOR
Intervention: Tissue-expander/prosthesis
Number of subjects: 196
Study 33200808 — intervention group
Group type: EXPERIMENTAL
Intervention: Polysaccharide hemostatic powder (PHP)
Number of subjects: 143
Study 33200808 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 143
Study 33200808 — intervention group
Group type: EXPERIMENTAL
Intervention: PHP (in subgroup analysis excluding antithrombotic agents)
Number of subjects: 143
Study 33200808 — intervention group
Group type: COMPARATOR
Intervention: Control (in subgroup analysis excluding antithrombotic agents)
Number of subjects: 143
Study 32078948 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon beta‐1a 125 mcg every 2 weeks
Number of subjects: 1243
Study 34501636 — intervention group
Group type: EXPERIMENTAL
Intervention: Door-to-door hang-up visits
Number of subjects: 4276
Study 34501636 — intervention group
Group type: COMPARATOR
Intervention: Conventional fixed distribution from distribution centers with mass distribution campaign
Number of subjects: 4276
Study 32141858 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxidative stress measured by malondialdehyde (MDA) content
Number of subjects: 81
Study 32141858 — intervention group
Group type: EXPERIMENTAL
Intervention: Antioxidant activity measured by catalase (CAT) content
Number of subjects: 81
Study 32141858 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart Rate Variability (HRV) analysis before physical activity
Number of subjects: 81
Study 32141858 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV spectral analysis before physical activity
Number of subjects: 81
Study 32141858 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV time analysis after physical activity
Number of subjects: 81
Study 32141858 — intervention group
Group type: EXPERIMENTAL
Intervention: HRV spectral analysis after physical activity
Number of subjects: 81
Study 35426796 — intervention group
Group type: EXPERIMENTAL
Intervention: Model group (n=856)
Number of subjects: 1141
Study 35426796 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group (n=258)
Number of subjects: 1141
Study 35426796 — intervention group
Group type: COMPARATOR
Intervention: High-risk group (identified by the risk score model)
Number of subjects: 1141
Study 35426796 — intervention group
Group type: COMPARATOR
Intervention: Risk factors identified
Number of subjects: 1141
Study 35426796 — intervention group
Group type: COMPARATOR
Intervention: Risk score model
Number of subjects: 1141
Study 32368344 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Resistance exercises (TRX)
Number of subjects: 36
Study 32368344 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic training
Number of subjects: 36
Study 32368344 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 36
Study 35731136 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol efflux capacity (CEC) of serum high-density lipoprotein (HDL)
Number of subjects: 0
Study 35731136 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum HDL cholesterol (HDL-C)
Number of subjects: 0
Study 35731136 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum ApoA1
Number of subjects: 0
Study 35731136 — intervention group
Group type: EXPERIMENTAL
Intervention: Decline in CEC
Number of subjects: 0
Study 35731136 — intervention group
Group type: EXPERIMENTAL
Intervention: CEC and ApoA1
Number of subjects: 0
Study 35731136 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster decliners in CEC
Number of subjects: 0
Study 33691647 — intervention group
Group type: EXPERIMENTAL
Intervention: Therap-i module integrated into treatment as usual (TAU) for depression
Number of subjects: 100
Study 33691647 — intervention group
Group type: COMPARATOR
Intervention: Control group (TAU without Therap-i module)
Number of subjects: 100
Study 32187977 — intervention group
Group type: EXPERIMENTAL
Intervention: Child Restraint System (CRS) usage
Number of subjects: 19
Study 32187977 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury related to unrestrained children
Number of subjects: 19
Study 32187977 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury Severity Score (ISS)
Number of subjects: 19
Study 35584882 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention group
Number of subjects: 440
Study 35584882 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive group
Number of subjects: 440
Study 35584882 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 440
Study 33183935 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-based total intravenous anesthesia
Number of subjects: 500
Study 33183935 — intervention group
Group type: COMPARATOR
Intervention: Volatile anesthesia
Number of subjects: 500
Study 33104761 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) and psychopharmacology within a collaborative care model
Number of subjects: 187
Study 33104761 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 187
Study 33104761 — intervention group
Group type: EXPERIMENTAL
Intervention: HDRS6
Number of subjects: 187
Study 35524492 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan-based hydrocolloid dressing
Number of subjects: 80
Study 35524492 — intervention group
Group type: COMPARATOR
Intervention: Inert saline gauze
Number of subjects: 80
Study 33855672 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalation Workshop
Number of subjects: 335
Study 35954675 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (2 sessions of 60 minutes per week for 9 months)
Number of subjects: 54
Study 35954675 — intervention group
Group type: COMPARATOR
Intervention: Control group (habitual leisure-time activities)
Number of subjects: 54
Study 33047258 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 110
Study 33047258 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Advice (BA)
Number of subjects: 110
Study 33047258 — intervention group
Group type: COMPARATOR
Intervention: Both interventions (MI and BA)
Number of subjects: 110
Study 32448335 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib mesylate (500 mg, once daily) combined with vinorelbine (40 mg, thrice a week)
Number of subjects: 238
Study 32448335 — intervention group
Group type: COMPARATOR
Intervention: Vinorelbine alone (40 mg, thrice a week)
Number of subjects: 238
Study 33515781 — intervention group
Group type: EXPERIMENTAL
Intervention: TAKE IT intervention (multifaceted medication adherence monitoring strategy)
Number of subjects: 450
Study 33515781 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 450
Study 32179587 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-coordinated referral with a comprehensive set of three lifestyle interventions (physical activity, weight reduction, smoking cessation)
Number of subjects: 824
Study 32179587 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 824
Study 33910103 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized 3D-printed guiding template (Group 2)
Number of subjects: 60
Study 33910103 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic type I tympanoplasty without template (Group 1)
Number of subjects: 60
Study 32142572 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen membrane (membrane group)
Number of subjects: 20
Study 32142572 — intervention group
Group type: COMPARATOR
Intervention: No collagen membrane (no-membrane group)
Number of subjects: 20
Study 36066557 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 530
Study 36066557 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study 34022839 — intervention group
Group type: EXPERIMENTAL
Intervention: Food Education and Sustainability Training (FEAST) program, delivered as a 1.5-h lesson/week for 10 weeks.
Number of subjects: 20
Study 34022839 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group (no intervention).
Number of subjects: 20
Study 34022839 — intervention group
Group type: EXPERIMENTAL
Intervention: Food literacy constructs including nutrition knowledge, food preparation and cooking skills, self-efficacy and behaviours, food waste knowledge and behaviours, and food production knowledge.
Number of subjects: 20
Study 34022839 — intervention group
Group type: EXPERIMENTAL
Intervention: Process evaluation measures including program reach, adoption, implementation, maintenance, satisfaction, and perceived benefits by teachers and students.
Number of subjects: 20
Study 35384335 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Giemsa Stain (MGS)
Number of subjects: 30
Study 35384335 — intervention group
Group type: COMPARATOR
Intervention: Leishman method
Number of subjects: 30
Study 35384335 — intervention group
Group type: COMPARATOR
Intervention: May Grunwald Giemsa method (MGG)
Number of subjects: 30
Study 32723486 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 61
Study 35925872 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional interventions with normoproteic diets (1.0 g/kg) after 60 days of KTx
Number of subjects: 174
Study 35925872 — intervention group
Group type: COMPARATOR
Intervention: Standard nutritional guidance for the post‐KTx period
Number of subjects: 174
Study 35925872 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional interventions
Number of subjects: 174
Study 35925872 — intervention group
Group type: COMPARATOR
Intervention: Standard nutritional guidance
Number of subjects: 174
Study 33285746 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 0
Study 33285746 — intervention group
Group type: COMPARATOR
Intervention: Control (no music intervention)
Number of subjects: 0
Study 35595091 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg daily in addition to standard care
Number of subjects: 5000
Study 35595091 — intervention group
Group type: COMPARATOR
Intervention: Placebo in addition to standard care
Number of subjects: 5000
Study 34266721 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ESWT)
Number of subjects: 29
Study 34266721 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose Prolotherapy
Number of subjects: 29
Study 32698962 — intervention group
Group type: EXPERIMENTAL
Intervention: 4D‐CT
Number of subjects: 0
Study 32698962 — intervention group
Group type: COMPARATOR
Intervention: 3D‐CT
Number of subjects: 0
Study 616845601 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxic bed rest (NBR)
Number of subjects: 11
Study 616845601 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic ambulatory confinement (HAMB)
Number of subjects: 11
Study 616845601 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic bed rest (HBR)
Number of subjects: 11
Study 35972927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazao Tickoff (active ingredient: M. anisopliae ICIPE 7)
Number of subjects: 1077
Study 35972927 — intervention group
Group type: EXPERIMENTAL
Intervention: Triatix® (active ingredient: amitraz)
Number of subjects: 1077
Study 35972927 — intervention group
Group type: COMPARATOR
Intervention: Placebo (excipients of the Mazao Tickoff)
Number of subjects: 1077
Study 35972927 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazao Tickoff
Number of subjects: 1077
Study 33772710 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention (5-week program)
Number of subjects: 91
Study 33772710 — intervention group
Group type: COMPARATOR
Intervention: Control (no-treatment)
Number of subjects: 91
Study 32668114 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated strategy of renal-replacement therapy (initiated within 12 hours)
Number of subjects: 2927
Study 32668114 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy of renal-replacement therapy (initiated after 72 hours or conventional indications)
Number of subjects: 2927
Study 32668114 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated strategy of renal-replacement therapy
Number of subjects: 2927
Study 32668114 — intervention group
Group type: COMPARATOR
Intervention: Standard strategy of renal-replacement therapy
Number of subjects: 2927
Study 35087261 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored intervention focused on reducing food waste during dining
Number of subjects: 0
Study 35087261 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 35087261 — intervention group
Group type: EXPERIMENTAL
Intervention: Individually tailored intervention
Number of subjects: 0
Study 37436461 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC, 45–60 s postpartum)
Number of subjects: 96
Study 37436461 — intervention group
Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC, < 10 s postpartum)
Number of subjects: 96
Study 32604130 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloud-based early warning score (mNEWS) intervention
Number of subjects: 1741
Study 32604130 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cloud-based early warning score)
Number of subjects: 1741
Study 35377866 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabrafenib, trametinib, and hydroxychloroquine (experimental arm)
Number of subjects: 14
Study 35377866 — intervention group
Group type: COMPARATOR
Intervention: Dabrafenib and trametinib (contemporary control arm)
Number of subjects: 14
Study 33980201 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized eHealth intervention including psycho-education, stress-management training (Heart Rate Variability-biofeedback), and a personalized stop-smoking plan.
Number of subjects: 0
Study 33980201 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized eHealth intervention
Number of subjects: 0
Study 33980201 — intervention group
Group type: COMPARATOR
Intervention: Control condition (webpage with information on pregnancy, stress, and smoking cessation)
Number of subjects: 0
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg every two weeks (Q2W) (400 mg at Weeks 0, 2, 4)
Number of subjects: 995
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 400 mg every two weeks (Q2W)
Number of subjects: 995
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients (combined CZP groups)
Number of subjects: 995
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg Q2W
Number of subjects: 995
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 400 mg Q2W
Number of subjects: 995
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: CZP 200 mg Q2W and CZP 400 mg Q2W
Number of subjects: 995
Study 32531798 — intervention group
Group type: EXPERIMENTAL
Intervention: All patients
Number of subjects: 995
Study 36464237 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 Hz electroacupuncture treatment
Number of subjects: 174
Study 36464237 — intervention group
Group type: EXPERIMENTAL
Intervention: 20/100 Hz electroacupuncture treatment
Number of subjects: 174
Study 36464237 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture treatment
Number of subjects: 174
Study 32388512 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step anesthesia
Number of subjects: 90
Study 32388512 — intervention group
Group type: COMPARATOR
Intervention: Peribulbar anesthesia
Number of subjects: 90
Study 32388512 — intervention group
Group type: COMPARATOR
Intervention: Retrobulbar anesthesia
Number of subjects: 90
Study 32734929 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-myofascial release intervention with a foam roller
Number of subjects: 70
Study 34499116 — intervention group
Group type: EXPERIMENTAL
Intervention: Dihydroartemisinin-piperaquine (DP)
Number of subjects: 554
Study 34134645 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic anticoagulation therapy
Number of subjects: 1032